{\reset@font\mtcSfont\mtc@string\contentsline{section}{\noexpand \leavevmode \numberline {10.1}CAGE-seq derived enhancers}{\reset@font\mtcSfont 77}{section.10.1}}
{\reset@font\mtcSfont\mtc@string\contentsline{section}{\noexpand \leavevmode \numberline {10.2}Enhancer intersection}{\reset@font\mtcSfont 79}{section.10.2}}
{\reset@font\mtcSfont\mtc@string\contentsline{section}{\noexpand \leavevmode \numberline {10.3}Enhancer clustering}{\reset@font\mtcSfont 81}{section.10.3}}
{\reset@font\mtcSSfont\mtc@string\contentsline{subsection}{\noexpand \leavevmode \numberline {10.3.1}Major cluster assignment by k-means}{\reset@font\mtcSSfont 81}{subsection.10.3.1}}
{\reset@font\mtcSfont\mtc@string\contentsline{section}{\noexpand \leavevmode \numberline {10.4}Additional plots for clades enriched for CAGE-enhancers}{\reset@font\mtcSfont 84}{section.10.4}}
{\reset@font\mtcSfont\mtc@string\contentsline{section}{\noexpand \leavevmode \numberline {10.5}ATAC-seq for enhancers in MLL-AF9\xspace leukemia}{\reset@font\mtcSfont 85}{section.10.5}}
